TY - JOUR
T1 - Validation of the 5-SNP score for the prediction of venous thromboembolism in a Danish fast-track cohort of 6,789 total hip and total knee arthroplasty patients
AU - Smeets, Mark J.R.
AU - Petersen, Pelle B.
AU - Jørgensen, Christoffer C.
AU - Cannegieter, Suzanne.C.
AU - Ostrowski, Sisse R.
AU - Kehlet, Henrik
AU - Nemeth, Banne
PY - 2025/1
Y1 - 2025/1
N2 - BACKGROUND: Venous thromboembolism (VTE) is a serious complication following total hip arthroplasty (THA) and total knee arthroplasty (TKA). Despite improvements with fast-track treatment protocols, 0.5% of patients still develop a VTE within 90-days postoperatively. Previously, the 5-single nucleotide polymorphism (SNP) genetic risk scores (weighted and simplified) were developed to identify people at a high risk for VTE within the general population.OBJECTIVES: We aimed to assess whether the 5-SNP scores could be used to identify high-risk patients in a cohort of fast-track THA/TKA patients.METHODS: A subset of patients from the Lundbeck Centre for Fast-track Hip and Knee Replacement Database was included based on the availability of genetic information. The 5-SNP scores were calculated for these patients, and their discriminatory performance was determined by c-statistic. Furthermore, the 5-SNP scores were added to a simple logistic prediction model containing clinical predictors to assess the added predictive value.RESULTS: A total of 7753 THA and TKA procedures (6798 patients) were included in this study. The c-statistics for the weighted and simple 5-SNP scores were 0.50 (95% CI, 0.39-0.61) and 0.48 (95% CI, 0.38-0.58), respectively. For the model with clinical predictors, the c-statistic was 0.67 (95% CI, 0.56-0.77). Addition of either of the 5-SNP scores did not improve discrimination in this model.CONCLUSION: These findings do not support genetic risk profiling in fast-track THA/TKA patients to predict VTE. Hence, efforts should be directed at optimizing prediction models with clinical predictors.
AB - BACKGROUND: Venous thromboembolism (VTE) is a serious complication following total hip arthroplasty (THA) and total knee arthroplasty (TKA). Despite improvements with fast-track treatment protocols, 0.5% of patients still develop a VTE within 90-days postoperatively. Previously, the 5-single nucleotide polymorphism (SNP) genetic risk scores (weighted and simplified) were developed to identify people at a high risk for VTE within the general population.OBJECTIVES: We aimed to assess whether the 5-SNP scores could be used to identify high-risk patients in a cohort of fast-track THA/TKA patients.METHODS: A subset of patients from the Lundbeck Centre for Fast-track Hip and Knee Replacement Database was included based on the availability of genetic information. The 5-SNP scores were calculated for these patients, and their discriminatory performance was determined by c-statistic. Furthermore, the 5-SNP scores were added to a simple logistic prediction model containing clinical predictors to assess the added predictive value.RESULTS: A total of 7753 THA and TKA procedures (6798 patients) were included in this study. The c-statistics for the weighted and simple 5-SNP scores were 0.50 (95% CI, 0.39-0.61) and 0.48 (95% CI, 0.38-0.58), respectively. For the model with clinical predictors, the c-statistic was 0.67 (95% CI, 0.56-0.77). Addition of either of the 5-SNP scores did not improve discrimination in this model.CONCLUSION: These findings do not support genetic risk profiling in fast-track THA/TKA patients to predict VTE. Hence, efforts should be directed at optimizing prediction models with clinical predictors.
KW - Hip
KW - Arthroplasty
KW - Replacement
KW - Knee
KW - Clinical Decision Rules
KW - Risk Assessment
KW - Venous Thromboembolism
KW - risk assessment
KW - venous thromboembolism
KW - clinical decision rules
KW - arthroplasty, replacement, knee
KW - arthroplasty, replacement, hip
UR - http://www.scopus.com/inward/record.url?scp=85212635678&partnerID=8YFLogxK
U2 - 10.1016/j.rpth.2024.102644
DO - 10.1016/j.rpth.2024.102644
M3 - Journal article
C2 - 39810985
SN - 2475-0379
VL - 9
JO - Research and practice in thrombosis and haemostasis
JF - Research and practice in thrombosis and haemostasis
IS - 1
M1 - 102644
ER -